Join
Live feed
·
INSIDERFilingvia Quantisnow
BeOne Medicines Ltd. logo

Global Head of R&D Wang Lai was granted 86,359 units of Ordinary Shares, increasing direct ownership by 9% to 1,058,304 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ONC· BeOne Medicines Ltd.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ONC (BeOne Medicines Ltd.) and more on Quantisnow.